公司概覽
業務類別 Biotechnology
業務概覽 Lycia Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.
公司地址 400 East Jamie Court, Suite 200, South San Francisco, CA, USA, 94080
電話號碼 +1 650 392-3357
傳真號碼 --
公司網頁 https://www.lyciatx.com
員工數量 31
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Aetna Wun Trombley, PhD President, Chief Executive Officer and Director -- 05/10/2026
Dr. Chin Lee, M.D.,M.P.H. Chief Medical Officer -- 05/10/2026
Ms. Amy Bachrodt Chief Financial Officer -- 05/10/2026
Mr. Steve Staben, PhD Chief Scientific Officer -- 05/10/2026
Dr. Sofia Touami Chief Business Officer -- 05/10/2026
 
董事會成員
董事會 職務 更新日期
Ms. Jane Pritchett Henderson Independent Director 05/10/2026
Mr. William J. Rieflin Chairman of the Board 05/10/2026
Dr. Laurent Fischer, M.D. Independent Director 05/10/2026
Dr. Aetna Wun Trombley, PhD President, Chief Executive Officer and Director 05/10/2026
Dr. Clare Ozawa, PhD Independent Director 05/10/2026
Mr. Tim Anderson Independent Director 05/10/2026
Mr. Ming Fang Independent Director 05/10/2026
 
所屬ETF (更新日期: 07/11/2026 02:43)
代號 名稱 佔比% ▼ 持有日期
TMEDT. Rowe Price Health Care ETF0.003%31/10/2026
TDNAT. Rowe Price Biotech ETF0.001%31/10/2026
TSEET. Rowe Price Small-Cap ETF0.0004%31/10/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.